LKFT — Lakefront Biotherapeutics NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual balance sheet for Lakefront Biotherapeutics NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	4,703	4,094	3,685	3,118	2,998
Net Total Accounts Receivable
Net Total Receivables	129	77.3	65.7	88.1	53.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,862	4,237	3,862	3,339	3,079
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	138	154	126	123	80.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	5,193	4,734	4,357	4,136	3,407
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	566	523	428	335	153
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	2,550	2,208	1,562	1,239	171
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2,643	2,526	2,796	2,897	3,236
Total Liabilities & Shareholders' Equity	5,193	4,734	4,357	4,136	3,407
Total Common Shares Outstanding